- Home
- FTHM vs PYPD Comparison
FTHM vs PYPD Comparison
Compare FTHM & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTHM
- PYPD
- Stock Information
- Founded
- FTHM 2010
- PYPD 2008
- Country
- FTHM United States
- PYPD Israel
- Employees
- FTHM N/A
- PYPD N/A
- Industry
- FTHM Real Estate
- PYPD Medical/Dental Instruments
- Sector
- FTHM Finance
- PYPD Health Care
- Exchange
- FTHM Nasdaq
- PYPD Nasdaq
- Market Cap
- FTHM 54.7M
- PYPD 60.4M
- IPO Year
- FTHM 2020
- PYPD 2020
- Fundamental
- Price
- FTHM $1.43
- PYPD $3.83
- Analyst Decision
- FTHM Strong Buy
- PYPD Strong Buy
- Analyst Count
- FTHM 1
- PYPD 5
- Target Price
- FTHM $2.50
- PYPD $12.00
- AVG Volume (30 Days)
- FTHM 231.2K
- PYPD 96.3K
- Earning Date
- FTHM 11-11-2025
- PYPD 11-12-2025
- Dividend Yield
- FTHM N/A
- PYPD N/A
- EPS Growth
- FTHM N/A
- PYPD N/A
- EPS
- FTHM N/A
- PYPD N/A
- Revenue
- FTHM $390,032,000.00
- PYPD N/A
- Revenue This Year
- FTHM $25.22
- PYPD N/A
- Revenue Next Year
- FTHM $16.19
- PYPD N/A
- P/E Ratio
- FTHM N/A
- PYPD N/A
- Revenue Growth
- FTHM 19.16
- PYPD N/A
- 52 Week Low
- FTHM $0.65
- PYPD $2.30
- 52 Week High
- FTHM $3.37
- PYPD $3.93
- Technical
- Relative Strength Index (RSI)
- FTHM 37.74
- PYPD 68.60
- Support Level
- FTHM $1.54
- PYPD $3.10
- Resistance Level
- FTHM $1.84
- PYPD $3.50
- Average True Range (ATR)
- FTHM 0.15
- PYPD 0.17
- MACD
- FTHM -0.02
- PYPD 0.07
- Stochastic Oscillator
- FTHM 10.91
- PYPD 93.59
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.